EVP & Chairman, Partnering · Royalty Pharma plc · Class A Ordinary Shares
Side
SELL
Value
$1.75M
Shares
32.4K
Price
$54.11
Executed
Jun 23, 2026
Disclosed
Jun 25, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jun 23 executedJun 25, 2026 disclosed
RPRX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Hite Christopher filed this Form 4 reporting a open-market sale of RPRX on Jun 23, 2026. It became public on Jun 25, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP & Chairman, Partnering
Hite Christophercik:0001814238
Issuer
Royalty Pharma plccik:0001802768
Revision history · 0
No field has changed since this record was first ingested.
